• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New Strategies.

作者信息

Proietti Marco, Lane Deirdre A

机构信息

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Geriatric Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

Thromb Haemost. 2020 Mar;120(3):369-371. doi: 10.1055/s-0040-1702231. Epub 2020 Mar 5.

DOI:10.1055/s-0040-1702231
PMID:32135563
Abstract
摘要

相似文献

1
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New Strategies.
Thromb Haemost. 2020 Mar;120(3):369-371. doi: 10.1055/s-0040-1702231. Epub 2020 Mar 5.
2
Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.日本非瓣膜性心房颤动急性卒中患者口服抗凝剂选择的趋势：SAMURAI-NVAF研究
Int J Stroke. 2015 Aug;10(6):836-42. doi: 10.1111/ijs.12452. Epub 2015 Jan 12.
3
Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.非维生素 K 拮抗剂口服抗凝剂与华法林在伴有房颤和既往卒中或短暂性脑缺血发作的患者中的比较：一项更新的随机对照试验的系统评价和荟萃分析。
Int J Stroke. 2017 Aug;12(6):589-596. doi: 10.1177/1747493017700663. Epub 2017 Mar 15.
4
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.真实世界中阿哌沙班在房颤卒中预防中的应用：系统评价和荟萃分析。
Stroke. 2018 Jan;49(1):98-106. doi: 10.1161/STROKEAHA.117.018395. Epub 2017 Nov 22.
5
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.心房颤动卒中后抗凝治疗的三个月风险效益概况：SAMURAI-非瓣膜性心房颤动（NVAF）研究
Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29.
6
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.真实世界环境中比较非维生素 K 拮抗剂口服抗凝药与维生素 K 拮抗剂预防心房颤动卒中：系统评价和荟萃分析。
Stroke. 2017 Sep;48(9):2494-2503. doi: 10.1161/STROKEAHA.117.017549. Epub 2017 Jul 17.
7
Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial.非维生素K拮抗剂口服抗凝剂和华法林对预防伴有非瓣膜性心房颤动且至少有一处微出血的急性缺血性卒中患者进一步发生脑微出血的有效性：CMB-NOW多中心试点试验
J Stroke Cerebrovasc Dis. 2019 Jul;28(7):1918-1925. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.050. Epub 2019 Apr 18.
8
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.非维生素 K 拮抗剂口服抗凝剂与华法林在 III 期心房颤动试验中的净临床获益。
Am J Med. 2015 Sep;128(9):1007-14.e2. doi: 10.1016/j.amjmed.2015.03.034. Epub 2015 Apr 22.
9
Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials.非维生素 K 拮抗剂口服抗凝剂在伴有心房颤动和既往卒中和短暂性脑缺血发作的患者中的应用：一项随机对照试验的系统评价和荟萃分析。
Stroke. 2012 Dec;43(12):3298-304. doi: 10.1161/STROKEAHA.112.673558. Epub 2012 Nov 13.
10
Underuse of anticoagulation in patients with atrial fibrillation.心房颤动患者抗凝治疗不足。
Postgrad Med. 2016;128(2):191-200. doi: 10.1080/00325481.2016.1132939. Epub 2016 Jan 8.

引用本文的文献

1
Pharmacy-Led Management of Atrial Fibrillation: Improving Treatment Adherence and Patient Outcomes.由药房主导的心房颤动管理：提高治疗依从性及改善患者预后
Integr Pharm Res Pract. 2024 Jul 29;13:101-114. doi: 10.2147/IPRP.S397844. eCollection 2024.
2
Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios.临床实践及复杂情况下接受直接口服抗凝剂治疗患者的管理
J Clin Med. 2023 Sep 13;12(18):5955. doi: 10.3390/jcm12185955.
3
Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists.
“心房颤动优化治疗（ABC）路径”与服用维生素K拮抗剂的心房颤动患者抗凝质量的关系
J Pers Med. 2022 Mar 17;12(3):487. doi: 10.3390/jpm12030487.
4
Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients.无症状与有症状心房颤动的结局比较：对81462例患者的系统评价和荟萃分析
J Clin Med. 2021 Sep 2;10(17):3979. doi: 10.3390/jcm10173979.
5
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.老年房颤患者抗凝治疗依从性差：来自优化老年房颤患者血栓预防（ChiOTEAF）登记研究的报告。
Eur Heart J Qual Care Clin Outcomes. 2023 Feb 28;9(2):169-176. doi: 10.1093/ehjqcco/qcab054.